27524875|t|Surgical Guidance via Multiplexed Molecular Imaging of Fresh Tissues Labeled with SERS -Coded Nanoparticles
27524875|a|The imaging of dysregulated cell-surface receptors (or biomarkers) is a potential means of identifying the presence of cancer with high sensitivity and specificity. However, due to heterogeneities in the expression of protein biomarkers in tumors, molecular imaging technologies should ideally be capable of visualizing a multiplexed panel of cancer biomarkers. Recently, surface-enhanced Raman-scattering (SERS) nanoparticles (NPs) have attracted wide interest due to their potential for sensitive and multiplexed biomarker detection. In this review, we focus on the most recent advances in tumor imaging using SERS -coded NPs. A brief introduction of the structure and optical properties of SERS NPs is provided, followed by a detailed discussion of key imaging issues such as the administration of NPs in tissue (topical versus systemic), the optical configuration and imaging approach of Raman imaging systems, spectral demultiplexing methods for quantifying NP concentrations, and the disambiguation of specific vs. nonspecific sources of contrast through ratiometric imaging of targeted and untargeted (control) NP pairs. Finally, future challenges and directions are briefly outlined.
27524875	0	8	Surgical	T061	C0543467
27524875	9	17	Guidance	T061	C1959633
27524875	22	51	Multiplexed Molecular Imaging	T060	C1537028
27524875	61	68	Tissues	T024	C0040300
27524875	69	76	Labeled	T130	C1522485
27524875	82	86	SERS	T070	C1720804
27524875	94	107	Nanoparticles	T073	C1450054
27524875	112	119	imaging	T060	C0011923
27524875	136	158	cell-surface receptors	T116,T192	C0034800
27524875	163	174	biomarkers)	T201	C0005516
27524875	215	223	presence	T033	C0150312
27524875	227	233	cancer	T191	C0006826
27524875	244	255	sensitivity	T169	C0332324
27524875	260	271	specificity	T081	C1511884
27524875	289	304	heterogeneities	T080	C0019409
27524875	312	333	expression of protein	T045	C1171362
27524875	334	344	biomarkers	T123	C0041366
27524875	348	354	tumors	T191	C0027651
27524875	356	373	molecular imaging	T060	C1537028
27524875	374	386	technologies	T058	C0752188
27524875	430	447	multiplexed panel	T130	C1254353
27524875	451	468	cancer biomarkers	T123	C0041366
27524875	480	513	surface-enhanced Raman-scattering	T070	C1720804
27524875	515	519	SERS	T070	C1720804
27524875	521	534	nanoparticles	T073	C1450054
27524875	536	539	NPs	T073	C1450054
27524875	597	606	sensitive	T169	C0332324
27524875	611	632	multiplexed biomarker	T130	C1254353
27524875	633	642	detection	T061	C1511790
27524875	652	658	review	T170	C0282443
27524875	700	705	tumor	T191	C0027651
27524875	706	713	imaging	T060	C0011923
27524875	720	724	SERS	T070	C1720804
27524875	732	735	NPs	T073	C1450054
27524875	765	774	structure	T082	C0678594
27524875	779	797	optical properties	T070	C1254365
27524875	801	805	SERS	T070	C1720804
27524875	806	809	NPs	T073	C1450054
27524875	864	871	imaging	T060	C0011923
27524875	891	905	administration	T169	C1621583
27524875	909	912	NPs	T073	C1450054
27524875	916	922	tissue	T024	C0040300
27524875	924	931	topical	T082	C0332237
27524875	939	947	systemic	T169	C0205373
27524875	954	975	optical configuration	UnknownType	C0678647
27524875	980	987	imaging	T060	C0011923
27524875	1000	1021	Raman imaging systems	T059	C1257898
27524875	1023	1054	spectral demultiplexing methods	T060	C1537028
27524875	1059	1070	quantifying	T081	C1709793
27524875	1071	1073	NP	T073	C1450054
27524875	1074	1088	concentrations	T081	C1446561
27524875	1098	1112	disambiguation	T080	C2346729
27524875	1116	1124	specific	T080	C0205369
27524875	1129	1140	nonspecific	T078	C0750540
27524875	1169	1188	ratiometric imaging	T060	C0011923
27524875	1192	1200	targeted	T169	C1521840
27524875	1205	1215	untargeted	T167	C1550141
27524875	1217	1224	control	T167	C1550141
27524875	1226	1228	NP	T073	C1450054